AnaptysBio
ANAB
ANAB
153 hedge funds and large institutions have $743M invested in AnaptysBio in 2025 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
13% more funds holding
Funds holding: 135 → 153 (+18)
11% more call options, than puts
Call options by funds: $5.68M | Put options by funds: $5.12M
2% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 43
Holders
153
Holding in Top 10
5
Calls
$5.68M
Puts
$5.12M
Top Buyers
| 1 | +$70M | |
| 2 | +$44M | |
| 3 | +$20.9M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$19.1M |
| 5 |
Citigroup
New York
|
+$18.9M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$20.9M | |
| 3 | -$20.8M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$9.29M |
| 5 |
State Street
Boston,
Massachusetts
|
-$7.9M |
